Search for: "TAKEDA PHARMACEUTICALS AMERICA, INC"
Results 41 - 60
of 65
Sorted by Relevance
|
Sort by Date
28 Jul 2015, 11:52 am
America, Inc., No. [read post]
3 Jan 2012, 5:38 pm
MDL Consolidation to eliminate duplicative discovery, prevent inconsistent pretrial rulings, and conserve the resources of the parties, their counsel and the judiciary Actos (pioglitazone) was marketed by Takeda Pharmaceuticals America Inc. and Eli Lilly and Co. in 1999 for the treatment of Type II diabetes. [read post]
13 Aug 2012, 7:02 pm
FDA Drug Safety Communication: Selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and reports of a rare heart and lung condition in newborn babies, FDA, December 14, 2011 Selective serotonin reuptake inhibitors, Mayo Clinic Birth Defects, Centers for Disease Control and Prevention More Blog Posts: Actos Lawsuits Allow Diabetes Patients to Pursue Dangerous Drug Compensation from Takeda Pharmaceuticals America, Inc., Drug Injury… [read post]
9 Dec 2009, 3:59 pm
Teva Pharmaceuticals USA Inc. [read post]
16 Jun 2011, 7:07 am
Food and Drug Administration today announced it has begun a safety review of the diabetes drug Actos (pioglitazone), after receiving preliminary results from a long-term observational study designed to evaluate the risk of bladder cancer associated with use of this drug.The preliminary results are based on five-year data from an ongoing, 10-year observational study by the manufacturer, Takeda Pharmaceuticals North America Inc., San Diego. [read post]
4 Jan 2012, 9:20 am
In August, Plaintiffs with pending lawsuits against Japanese company Takeda Pharmaceuticals America Inc. [read post]
5 Jan 2012, 3:10 pm
In August, Plaintiffs with pending lawsuits against Japanese company Takeda Pharmaceuticals America Inc. [read post]
13 Nov 2019, 12:23 pm
Here is a list of our earlier 2019 Uloric articles: Uloric Lawsuits Involving Heart Attacks And Strokes Follow Recent FDA Warnings About Cardiovascular Deaths (April 2019) Uloric "Black-Box Warning" For Increased Risks Of Heart-Related Deaths And Cardiovascular Side Effects (March 2019) Uloric Recall, "Black-Box Warning", And Limited Use Discussed By FDA Advisory Committees In January 2019 (January 2019) We are investigating Uloric drug injury cases against… [read post]
8 Aug 2012, 8:30 pm
(BSX), Murray Hill, Johnson & Johnson (JNJ), Endo Pharmaceutical Holdings Inc., and other companies. [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of… [read post]
2 May 2013, 9:55 am
Takeda Pharmaceuticals America, Inc., LASC No. [read post]
6 Mar 2014, 12:41 pm
Pfizer, Inc., 490 F. [read post]
27 Sep 2009, 5:13 pm
Takeda Chemical Industries, Ltd., et al. [read post]
9 Apr 2014, 12:33 pm
Takeda Pharmaceuticals North America Inc., 12-cv-00064. [read post]
20 Nov 2013, 4:30 am
Takeda Pharmaceuticals North America, Inc., 2013 U.S. [read post]
16 Aug 2013, 11:10 am
Takeda Pharmaceuticals America, Inc., 2013 WL 4040395 (E.D. [read post]
30 Mar 2015, 12:18 pm
Takeda Pharmaceuticals North America, Inc., No. [read post]
22 Jan 2013, 8:50 am
Takeda Pharmaceuticals North America, Inc., 2013 U.S. [read post]
31 Oct 2008, 3:34 pm
” Moving on several years to March 2007, the FDA notified Takeda Pharmaceuticals of North America, Inc. that its diabetes drug, Actos was responsible for increased incidents of bone fractures in women using the drug. [read post]
26 Mar 2014, 7:38 pm
Takeda Pharmaceuticals, Inc. [read post]
